With the analysis among 98 patents, we discovered top 53 key players by total patent application. EngMab SARL, Bio-Thera Solutions, Ltd., Bristol Myers Squibb Co. are dominant in this area. They take 18.37% of the total patent filing.
Schwyz, Switzerland
Patent: 9
Bio-Thera Solutions, Ltd.
Guangdong Sheng, China
Patent: 5
New York, United States
Patent: 4
LegoChem Biosciences, Inc.
Centre of Molecular Immunology
California, United States
Patent: 3
Washington, United States
Patent: 3
Vaud, Switzerland
Patent: 3
Antwerpen, Belgium
Patent: 3
With the analysis among 3 patents, we discovered top 2 start-ups by total patent application.
Institut National de la Santé et de la Recherche Médicale
Gammadelta Therapeutics Ltd.
With the analysis among related 51 patents applied in the last 5 years. We discover 34 most active companies in this area. The fast-growing EngMab SARL, LegoChem Biosciences, Inc., Centre of Molecular Immunology take 27.45% of patent filing during this period.
Schwyz, Switzerland
Patent: 6
LegoChem Biosciences, Inc.
Centre of Molecular Immunology
Ludwig Institute for Cancer Research Ltd.
New York, United States
Patent: 2
EPIMAB BIOTHERAPEUTICS (HK)LIMITED
undefined undefined
Patent: 2
ZURICH, Switzerland
Patent: 2
EpimAb Biotherapeutics (Suzhou) Co. Ltd.
Antwerpen, Belgium
Patent: 2
Shanghai EpimAb Biotherapeutics Co. Ltd.
Shanghai Shi, China
Patent: 2
With the analysis among related 51 patents in last 5 years, we discover 25 new entrants. LegoChem Biosciences, Inc., Centre of Molecular Immunology, YBiologics, Inc. are the most active new entrants in this area.
LegoChem Biosciences, Inc.
Centre of Molecular Immunology
EPIMAB BIOTHERAPEUTICS (HK)LIMITED
undefined undefined
Patent: 2
ZURICH, Switzerland
Patent: 2
EpimAb Biotherapeutics (Suzhou) Co. Ltd.
Shanghai EpimAb Biotherapeutics Co. Ltd.
Shanghai Shi, China
Patent: 2
With the analysis among 27 patents, we discovered top 3 universities and scientific research institutions by total patent application.
New York, United States
Patent: 3
Université d'Aix-Marseille